Browse Drug Recalls
14,449 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 14,449 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 14,449 FDA drug recalls, Class II.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Aug 14, 2023 | All Over-The-Counter (OTC) drug products warehoused, salvaged, and sold by In... | CGMP Deviations: Potential exposure to rodents and rodent activity in the distribution center. Al... | Class II | Inmar Supply Chain Solutions, LLC |
| Aug 11, 2023 | DIANEAL Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution 1.5% Dextrose, p... | Lack of Assurance of Sterility: Potential presence of leaks originating from the Luer component. | Class II | Baxter Healthcare Corporation |
| Aug 11, 2023 | Sodium Fluoride 1.1%, SODIUM FLUORIDE Prescription Dental Toothpaste, 5000 pp... | Cases of Sodium Fluoride 1.1% Prescription Dental Toothpaste may contain cartons labeled as Capsa... | Class II | AVKARE LLC |
| Aug 11, 2023 | Dianeal PD-2 Peritonial Dialysis Solution with 1.5% Dextrose, 5000 mL AMBU-FL... | Lack of Assurance of Sterility: Potential presence of leaks originating from the Luer component. | Class II | Baxter Healthcare Corporation |
| Aug 11, 2023 | Capsaicin Cream 0.025%, External Analgesic Cream, Penetrating Pain Relief, NE... | Product mix-up: Cartons labeled Capsaicin Cream 0.025% may contain tubes of Sodium Fluoride 1.1% ... | Class II | AVKARE LLC |
| Aug 10, 2023 | hello wild strawberry fluoride toothpaste, sodium fluoride 0.24% (0.15% w/v f... | Labeling: Label Mix-Up: Some hello wild strawberry fluoride toothpaste, packaged in cartons label... | Class II | Colgate Palmolive Company |
| Aug 9, 2023 | YAGER'S LINIMENT (Camphor and Turpentine Oil) 3.1% and 8.12% respectively, pa... | CGMP Deviations: Products not manufactured under current good manufacturing practices. | Class II | Ecometics, Inc. |
| Aug 9, 2023 | Unguentine Ointment, (Camphor 3.0%, Phenol 2.5%, Tannic Acid 2.2%, Zinc Oxide... | CGMP Deviations: Products not manufactured under current good manufacturing practices. | Class II | Ecometics, Inc. |
| Aug 9, 2023 | ALCOLADO RELAMPAGO (Menthol and Camphor), 1% and 1.5% respectively, packaged ... | CGMP Deviations: Products not manufactured under current good manufacturing practices. | Class II | Ecometics, Inc. |
| Aug 9, 2023 | Lugol's (Strong Iodine Solution USP), Each mL contains Iodine 0.05gm and pota... | CGMP Deviations: Products not manufactured under current good manufacturing practices. | Class II | Ecometics, Inc. |
| Aug 9, 2023 | activator concentrate, Sodium Fluoride 0.96% in Activator Concentrate; 0.08% ... | CGMP Deviations: Products not manufactured under current good manufacturing practices. | Class II | Ecometics, Inc. |
| Aug 9, 2023 | Blis-To-Sol Liquid (Tolnaftate), 1%, packaged in a) 1 FLUID OZ. (29.5 mL) bot... | CGMP Deviations: Products not manufactured under current good manufacturing practices. | Class II | Ecometics, Inc. |
| Aug 9, 2023 | AstrinGyn (Ferric Subsulfate) Aqueous, 259 mg/g, 8 gm Single Use Vials, Manuf... | CGMP Deviations: Products not manufactured under current good manufacturing practices. | Class II | Ecometics, Inc. |
| Aug 2, 2023 | Helix CBD Therapy Cream (Menthol 7.4%), packaged in a) 3 g pouch (NDC 30775-0... | CGMP Deviations | Class II | Parker Laboratories, Inc. |
| Aug 2, 2023 | Helix Tri-Active Therapy Cream (Camphor 3.2%, Menthol 7.4%, Methyl salicylate... | CGMP Deviations | Class II | Parker Laboratories, Inc. |
| Aug 2, 2023 | Helix Pain Relieving Cream (Menthol 7.4%), packaged in a) 5 gm pouch (NDC 307... | CGMP Deviations | Class II | Parker Laboratories, Inc. |
| Aug 2, 2023 | Helix CBD Clinical Cream (Menthol 7.4%), packaged in a)3 gm pouches (NDC30775... | CGMP Deviations | Class II | Parker Laboratories, Inc. |
| Aug 2, 2023 | Rasagiline Tablets 0.5mg, 30-count bottle, Rx only, Mylan Pharmaceuticals Inc... | Failed dissolution specifications - results obtained were below spec average. | Class II | Aurobindo Pharma USA Inc. |
| Aug 2, 2023 | Protex Foaming Hand Sanitizer (Benzalkonium Chloride 0.13%), packaged in a) 2... | CGMP Deviations | Class II | Parker Laboratories, Inc. |
| Jul 21, 2023 | Rufinamide Tablets, USP 400 mg, packaged in 120-count bottle, Rx only, Distri... | cGMP deviations: Batch was released prior to approval. | Class II | Aurobindo Pharma USA Inc. |
| Jul 21, 2023 | Cromolyn Sodium Oral Solution (Concentrate) 100 mg/5 mL 96 Plastic Ampules pe... | CGMP deviation: product released prior to supplier approval. | Class II | The Ritedose Corporation |
| Jul 21, 2023 | Rufinamide Tablets, USP 200 mg, packaged in 120-count bottle, Rx only, Distri... | cGMP deviations: Batch was released prior to approval. | Class II | Aurobindo Pharma USA Inc. |
| Jul 20, 2023 | FentaNYL 500 mcg/250 mL - Bupivacaine HCl 0.1% in 0.9% Sodium Chloride 250mL ... | cGMP deviations: due to shipment of rejected units. | Class II | SCA Pharmaceuticals |
| Jul 17, 2023 | succinylcholine, 200 mg/10 mL, (20 mg/mL), 10 mL syringe, Rx only, CAPS, Inc.... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | fentaNYL 2 mcg/mL and bupivacaine 0.0625% PF in 0.9% sodium chloride, Total V... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | morphine in 0.9% sodium chloride, 30 mg/30 mL, (1 mg/mL), 30 mL Syringe, Rx o... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | fentaNYL in dextrose 5%, 300 mcg/30 mL, (10 mcg/mL), 30 mL syringe, Rx only, ... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | fentaNYL in 0.9% sodium chloride, 1000 mcg/100 mL, (10 mcg/mL), 100 mL bag, R... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | ketamine in 0.9% sodium chloride, 50 mg/5mL (10mg/mL), 5 mL syringe, Rx only... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | vecuronium, 10 mg/10mL, (1 mg/mL), 10 mL syringe, Rx only, PARALYZING AGENT, ... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | PHENYLephrine in 0.9 sodium chloride, 400 mcg /10 mL, (40 mcg/mL), 10 mL Syri... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | HYDROmorphone in 0.9% sodium chloride, 6 mg/30 mL, (0.2 mg/mL), 30 mL Syringe... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | fentaNYL 2 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride / Total V... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | HYDROmorphone in 0.9% sodium chloride, 15 mg/30 mL, (0.5 mg/mL), 30 mL Syring... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | PHENYLephrine in 0.9 sodium chloride, 800 mcg /10 mL, (80 mcg/mL), 10 mL Syri... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | fentaNYL, 2500 mcg/50 mL, (50 mcg/mL), 100 mL bag, Central Admixture Pharmacy... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | PHENYLephrine in 0.9% sodium chloride, 1000 mcg/10 mL, (100 mcg/mL), 10 mL sy... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | HYDROmorphone added to 0.9% sodium chloride, 10 mg/50 mL, (0.2 mg/mL), 100 mL... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | HYDROmorphone in dextrose 5%, 3 mg/30 mL, (0.1 mg/mL), 30 mL Syringe, Rx only... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | morphine in 0.9% sodium chloride, 125 mg/25 mL, (5 mg/mL), 30 mL Syringe, Rx ... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | morphine in 0.9% Sodium Chloride, 50 mg/50 mL (1mg/mL), 50 mL Syringe, Rx onl... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | fentaNYL in 0.9% sodium chloride, 5000 mcg/250 mL, (20 mcg/mL), 250 mL Bag, R... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | fentaNYL in 0.9% sodium chloride, 2500 mcg/250 mL, (10 mcg/mL), 250 mL bag, R... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | midazolam in dextrose 5%, 50 mg /50 mL, (1 mg/mL), 50 mL Syringe, Rx only, Ce... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | fentaNYL 1.5 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride, Total ... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | fentaNYL, 1250 mcg/25 mL, (50 mcg/mL), 30 mL Syringe, Rx only, Central Admixt... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | fentaNYL in 0.9% sodium chloride, 10 mcg/1 mL, (10 mcg/mL), 3 mL Syringe, Rx ... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | HYDROmorphone in 0.9% sodium chloride, 10 mg/50 mL, (0.2 mg/mL), 50 mL Syring... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | lidocaine 2%, 100 mg /5 mL, (20 mg/mL), 5 mL Syringe, Rx only, CAPS, Inc., 79... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
| Jul 17, 2023 | fentaNYL, 5000 mcg/100 mL, (50 mcg/mL), 100 mL Bag, Rx only, Central Admixtur... | Lack of assurance of sterility: Lack of validation data for sanitization cycles | Class II | Central Admixture Pharmacy Services Inc |
Frequently Asked Questions
When a drug safety issue is identified, through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks, the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.